FDA Inspection 1251820 — Children's Hospital Los Angeles

Children's Hospital Los Angeles — FEI 2016501

The FDA completed an inspection of Children's Hospital Los Angeles on October 9, 2024 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 9, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)